• Publications
  • Influence
Development of the New Lung Allocation System in the United States
This article reviews the development of the new U.S. lung allocation system that took effect in spring 2005. In 1998, the Health Resources and Services Administration of the U.S. Department of HealthExpand
  • 528
  • 31
Report of the Crystal City Meeting to Maximize the Use of Organs Recovered from the Cadaver Donor
A consensus meeting to develop guidelines that would improve the recovery and transplantation of organs from the cadaver donor was held on 28–29 March 2001, in Crystal City, Virginia, sponsored byExpand
  • 316
  • 23
  • PDF
Analysis of risk factors for the development of bronchiolitis obliterans syndrome.
Chronic rejection after lung transplantation, manifesting as bronchiolitis obliterans syndrome (BOS), has become the dominant challenge to long-term patient and graft survival. In order to elucidateExpand
  • 249
  • 14
Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
Background Telomerase is an enzyme that catalyzes the addition of nucleotides on the ends of chromosomes. Rare loss of function mutations in the gene that encodes the protein component of telomeraseExpand
  • 248
  • 11
  • PDF
Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts
BackgroundAlthough the sequence of the human cytomegalovirus (HCMV) genome is generally conserved among unrelated clinical strains, some open reading frames (ORFs) are highly variable. UL146 andExpand
  • 57
  • 10
Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation
BACKGROUND Cytomegalovirus (CMV) is the most prevalent opportunistic infection after lung transplantation. Current strategies do not prevent CMV in most at-risk patients. OBJECTIVE To determineExpand
  • 187
  • 7
  • PDF
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.
From the Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine inExpand
  • 82
  • 6
  • PDF
Aspergillus and lung transplantation.
BACKGROUND Aspergillus infection is a known complication of transplantation. METHODS We describe our experience with 37 patients who received lung transplants over 2 years at Loyola UniversityExpand
  • 96
  • 5
Aggressive pharmacologic donor management results in more transplanted organs1
Background. Brain death results in adverse pathophysiologic effects in many cadaveric donors, resulting in cardiovascular instability and poor organ perfusion. Hormonal resuscitation (HR) has beenExpand
  • 261
  • 4